본문으로 건너뛰기
← 뒤로

Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.

Leukemia 2026 Vol.40(1) p. 262

DiNardo CD, Jen WY, Takahashi K, Kadia TM, Loghavi S, Daver NG, Xiao L, Reville PK, Issa GC, Short NJ, Sasaki K, Wang SA, Mullin JK, Pierce S, Bradley C, Borthakur G, Maiti A, Alvarado Y, Pemmaraju N, Ferrajoli A, Swaminathan M, Ohanian M, Abbas HA, Hammond D, Burger J, Haddad F, Montalban-Bravo G, Chien K, Masarova L, Yilmaz M, Jain N, Andreeff M, Garcia-Manero G, Kornblau S, Ravandi F, Jabbour E, Konopleva MY, Kantarjian HM

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA DiNardo CD, Jen WY, et al. (2026). Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.. Leukemia, 40(1), 262. https://doi.org/10.1038/s41375-025-02827-9
MLA DiNardo CD, et al.. "Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia.." Leukemia, vol. 40, no. 1, 2026, pp. 262.
PMID 41372600

같은 제1저자의 인용 많은 논문 (1)